(21. May 2025):
Erratum : Targeting the Isoprenoid Pathway in Choleste Biosynthesis. An Approach to Identify Isoprenoid Biosynthesis Inhibitors.
In: Archiv der Pharmazie, Vol. 358, No. 5, e70016
[PDF, 93kB]
This is the latest version of this item.
DOI: 10.1002/ardp.70016
| Item Type: | Journal article |
|---|---|
| Faculties: | Chemistry and Pharmacy > Department of Pharmacy |
| Subjects: | 500 Science > 540 Chemistry |
| URN: | urn:nbn:de:bvb:19-epub-128146-6 |
| ISSN: | 0365-6233 |
| Annotation: | Erratum: In the title of the article published as Arch. Pharm. 2025;358:e2400807, https://doi.org/10.1002/ardp.202400807, the word cholesterol was misrepresented as cholestero. The correct title is: Targeting the isoprenoid pathway in cholesterol biosynthesis: An approach to identify isoprenoid biosynthesis inhibitors Erratum Original Article see https://doi.org/10.1002/ardp.202400807 |
| Language: | English |
| Item ID: | 128146 |
| Date Deposited: | 16. Oct 2025 13:28 |
| Last Modified: | 16. Oct 2025 13:28 |
Available Versions of this Item
-
Targeting the isoprenoid pathway in choleste biosynthesis: An approach to identify isoprenoid biosynthesis inhibitors. (deposited 16. Sep 2025 09:31)
- Erratum : Targeting the Isoprenoid Pathway in Choleste Biosynthesis. (deposited 16. Oct 2025 13:28) [Currently Displayed]
Actions (login required)
- View Item
